1. Dehestani, V., et al. (2015). Liver toxicity in rheumatoid arthritis patients treated with methotrexate. Asia Pacific Journal of Medical Toxicology, 4(3), 102–105.
2. Ghoryani, M., et al. (2019). Amelioration of clinical symptoms of patients with refractory rheumatoid arthritis following treatment with autologous bone marrow-derived mesenchymal stem cells: a successful clinical trial in Iran. Biomedicine & Pharmacotherapy, 109, 1834–1840.
3. Sarabi, Z. S., et al. (2016). Evaluation of the anti-inflammatory effects of atorvastatin on patients with rheumatoid arthritis: a randomized clinical trial. Electronic Physician, 8(8), 2700–2706.
4. Pache, M., et al. (2002). Elevated plasma endothelin-1 levels and vascular dysregulation in patients with rheumatoid arthritis. Medical Science Monitor, 8(9), CR616–CR619.
5. Haq, A., et al. (1999). Serum and synovial fluid concentrations of endothelin-1 in patients with rheumatoid arthritis. Journal of Medicine, 30(1-2), 51–60.